Transtyretin is bound to RBP4 in plasma and an elevation in RBP4 is thought to contribute to the development of IR associated with obesity and T2DM [30] A decrease in transthyretin could result in increased free RBP4 levels contributing to IR in obese subjects, with weight loss improving this impairment. The gene discussed is RBP4; the disease is obesity disorder.